Biomerica (BMRA) Return on Capital Employed Growth (5y) (2016 - 2026)
Biomerica (BMRA) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -8,486.00 |
| Nov 30, 2025 | -6,845.00 |
| Aug 31, 2025 | -7,584.00 |
| May 31, 2025 | -8,002.00 |
| Feb 28, 2025 | -4,297.00 |
| Nov 30, 2024 | -5,292.00 |
| Aug 31, 2024 | -4,799.00 |
| May 31, 2024 | -2,187.00 |
| Feb 29, 2024 | -1,797.00 |
| Nov 30, 2023 | -1,298.00 |
| Aug 31, 2023 | -1,258.00 |
| Aug 31, 2022 | -2,787.00 |
| May 31, 2022 | -1,617.00 |
| Feb 28, 2022 | -2,949.00 |
| Nov 30, 2021 | -6,145.00 |
| Aug 31, 2021 | -5,448.00 |
| May 31, 2021 | -5,085.00 |
| Feb 28, 2021 | -4,121.00 |
| Nov 30, 2020 | -3,150.00 |
| Aug 31, 2020 | -1,855.00 |